Company intelligence / Profile preview

Edge

United Kingdom

Ownership: Private
Employees: ~10
Development stage: Other

Overview

Edge Biotech utilizes proprietary stem cell bioengineering to produce sustainable, animal-free bioactive ingredients for cosmetic and personal care products. Efficacy confirmed by compounded secretome effects, delivering enhanced biological performance with cost benefits to partners.

Therapeutic areas: HematologyDermatology
Modalities: Stem cell-derived bioactive ingredientProteinExosome-based therapy
Industry: Non-Drug Biotech

Partnerships

Seeking B2B distribution and industry partnerships

Beyond the preview

Go deeper on Edge.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Edge.

Explore the full profile